BIIB (biogen.com) Kompaniyaning sof foydasi

biogen.com (BIIB) kompaniyasining rasmiy ramzlari

Biogen Inc. global sherikliklar va startaplarni sotib olish orqali o'zining neyrofarmatsevtika yo'nalishini kengaytirmoqda. Biroq, tartibga soluvchi xavflar va klinik sinovlarning murakkabligi sezilarli bosim yaratmoqda. Shu bilan birga, kompaniya ishlab chiqarishni dekabonizatsiyaga qaratgan ekologik strategiyani amalga oshirmoqda. Kompaniyaning umumiy moliyaviy natijasi kirish nuqtalarini aniqlashga yordam beradi, 0.82 esa eng so'nggi foyda dinamikasini aks ettiruvchi joriy metrika qiymatini ifodalaydi.

BIIB Biogen Kompaniyaning sof foydasi (04.07.2022 - 29.10.2026)

Biogen (BIIB) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi Biogen Idec|BIIB - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor qiymati Biogen Idec|BIIB - Korxona qiymati
- balans kapitallashuvi ko'rsatkichlari:
Aksiya hisobiga sof aktivlar Biogen|BIIB - Kompaniyaning balans qiymati|Bozor qiymatining balans qiymatiga koeffitsiyenti biogen.com|BIIB - Kompaniyaning umumiy aktivlari
- qarz yuki va likvidlik ko'rsatkichlari:
Qarzning kapitalga nisbati Biogen Inc.|BIIB - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati Biogen Inc|BIIB - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Biogen Idec|BIIB - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli kredit va qarzlari Biogen|Oraliq qoplama koeffitsiyenti biogen.com
- foyda va multiplikatorlar bo'yicha ma'lumotlar:
BIIB - Kompaniyaning sof foydasi
Kompaniyaning asosiy tahlili:Biogen Idec
Biogen Inc. original mahsuloti

Biogen Inc. (BIIB) foydasi barcha operatsion va soliq xarajatlari chegirib tashlangangandan keyingi yakuniy sof daromadni ifodalaydi. Investorlar ushbu ko'rsatkichdan real vaqt rejimida naqd pul generatsiya qilish samaradorligini va kapital himoyasini baholash uchun foydalanadilar. Kompaniyaning konsolidatsiyalashgan foydasini tahlil qilish yashirin rentabellik tendentsiyalarini aniqlash imkonini beradi. Biogen Inc. (BIIB) holatida, konsolidatsiyalashgan foyda tendentsiyasi eski mahsulotlarning marjga ko'rsatayotgan bosimini aks ettiradi. Yangi dori vositalarini targ'ib qilish bilan bog'liq ortib borayotgan xarajatlar foydaning tiklanishiga to'sqinlik qilmoqda.

Muhim raqobatchilar

Kompaniyaning sof daromadi Neurocrine Corp (NBIX)|RGC (Regencell Bioscience) - Sof foyda|Kompaniyaning sof foydasi AXSM|Sof foyda ACAD|Sof moliyaviy natija Xenon Pharmaceuticals Inc.|Kompaniyaning sof foydasi Viking Pharma VKTX|Supernus Corp (SUPN) - Kompaniyaning sof daromadi|Catalyst Pharmaceuticals - Sof foyda|Yillik sof foyda denalitherapeutics.com (DNLI)|HRMY: Sof foyda|Kompaniyaning sof daromadi Biohaven Ltd (BHVN)|Kompaniyaning sof foydasi Amylyx|Kompaniya foydasi TRVI (Trevi Corp)|Sof daromad PRAX (Praxis Precision Medicines)|AVXL (anavex.com) - Yakuniy foyda|Sof foyda CBLL (CeriBell)|Sof moliyaviy natija Prothena Corp (PRTA)|ALEC - Kompaniyaning sof foydasi|ANNX (Annexon Biosciences Inc.) - Kompaniya foydasi|OMER: Sof foyda|Sof daromad neurogene.com|Sof daromad ACIU|Voyager Therapeutics Inc (VYGR) - Sof moliyaviy natija|Sof foyda NMRA|Kompaniyaning sof foydasi SCLX (Scilex Holding Company, Inc.)|Sof foyda TVGN (Tevogen Bio Holdings)|Sof moliyaviy natija Alpha Cognition Inc (ACOG)|Cognition Therapeutics - Sof foyda|Sof moliyaviy natija Inhibikase Therapeutics Inc IKT|SAVA: Sof foyda|ASRT (Assertio) - Kompaniyaning sof foydasi|Kompaniyaning sof foydasi Coya Therapeutics Inc|Kompaniya foydasi VTGN (VistaGen Therapeutics Inc)|Sof foyda OVID|ABOS - Kompaniyaning sof daromadi|CervoMed Inc - Sof daromad|Sof foyda Alterity Therapeutics Ltd. ATHE|CLNN - Kompaniyaning sof foydasi|Yakuniy foyda PEPG (PepGen Inc.)|Jupiter Neurosciences Inc (JUNS) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Relmada Therapeutics Inc (RLMD)|ANVS (Annovis Bio Corp) - Sof foyda|Kompaniyaning sof foydasi GRCE|Sof foyda AIFF|Sof moliyaviy natija anewmeds.com|Kompaniyaning sof foydasi NeuroSense Therapeutics Ltd. NRSN|Reviva Pharmaceuticals Holdings Inc. (RVPH) - Kompaniyaning sof daromadi|MetaVia, Inc. - Sof foyda|Yillik sof foyda NeurAxis Inc (NRXS)|HSDT: Sof foyda|Kompaniyaning sof daromadi Passage Bio (PASG)|Kompaniyaning sof foydasi Neuphoria Therapeutics, Inc.|Kompaniya foydasi NERV (Minerva Neurosciences Inc)|Sof daromad ATHA (Athira)|ADXN (Addex) - Yakuniy foyda|Sof foyda ALZN (Alzamend Neuro)|Sof moliyaviy natija Cyclerion Therapeutics Inc. (CYCN)|PTIX - Kompaniyaning sof foydasi|KTTA (Pasithea Therapeutics) - Kompaniya foydasi|CRGT: Sof foyda|Sof daromad Avenue Therapeutics Inc|Sof daromad BCLI|caratherapeutics.com (CARA) - Sof moliyaviy natija|Sof foyda CHRO|Kompaniyaning sof foydasi ELYM (eliemtx.com)|Sof foyda ITCI (Intra-Cellular Therapies, Inc.)|Sof moliyaviy natija Longboard (LBPH)|Marinus Pharmaceuticals - Sof foyda|Sof moliyaviy natija nkgenbiotech.com NKGN|NRBO: Sof foyda|SAGE (Sage Therapeutics Inc.) - Kompaniyaning sof foydasi|Kompaniyaning sof foydasi Neurotrope|Kompaniya foydasi TRVN (Trevena Inc)|Sof foyda VIGL|WENA - Kompaniyaning sof daromadi|Cerevel Therapeutics, Inc. - Sof daromad